Civic AI
Civic AI
Procurement intelligence
SAM.govRRPV-HPAD
Open

High Performance Antigen Diagnostics

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · DC
Response deadline
Jul 17, 2026
Due in 0 days
Date posted
Jun 17, 2026

Description

“High Performance Antigen Diagnostics” Request for Information (RFI) Purpose The Rapid Response Partnership Vehicle (RRPV) is issuing this Request for Information (RFI) to better understand the research, development, and product landscape of current and next-generation high performance immunoassay technologies suitable for antigen testing in near-patient settings. While conventional antigen-based immunoassays offer speed, ease of use, and low cost, they remain limited by lower analytical sensitivity and limited multiplexing capability compared to nucleic acid amplification tests (NAATs), limiting their clinical utility, particularly for early infections and syndromic panels.

Classifications

Documents (1)

Contacts

Explore more